DSGN
Design Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
Largest filed tie
—
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | SR One Capital ManagementSR One | $94.4M | 14.55% | 0.00% | |
| 2 | Logos Global ManagementLogos Global | $43.4M | 6.69% | +53.85% | |
| 3 | Baker Bros. AdvisorsBaker Bros. | $38.8M | 5.97% | +3.58% | |
| 4 | Driehaus Capital ManagementDriehaus | $38.5M | 5.93% | +52.50% | |
| 5 | BlackRockBlackRockindex-like | $38.5M | 5.93% | +24.66% | |
| 6 | Caption ManagementCaption | $37.9M | 5.84% | +2919.44% | |
| 7 | Point72 Asset ManagementPoint72 | $34.2M | 5.28% | −13.09% | |
| 8 | Trails Edge Capital PartnersTrails Edge Capital Partners | $29.0M | 4.46% | +134.89% | |
| 9 | Frazier Life Sciences ManagementFrazier Life Sciences | $26.2M | 4.03% | new | |
| 10 | Vivo CapitalVivo Capital | $23.3M | 3.60% | 0.00% | |
| 11 | Vanguard Capital ManagementVanguardindex-like | $22.7M | 3.50% | +16.38% | |
| 12 | Almitas CapitalAlmitas Capital | $14.9M | 2.29% | −32.90% | |
| 13 | Geode Capital ManagementGeodeindex-like | $13.9M | 2.14% | +38.40% | |
| 14 | Sofinnova InvestmentsSofinnova | $12.5M | 1.93% | new | |
| 15 | FMRFMR | $11.2M | 1.73% | −2.75% | |
| 16 | Morgan StanleyMorgan Stanley | $11.1M | 1.71% | +16.58% | |
| 17 | State StreetState Streetindex-like | $10.7M | 1.64% | +11.62% | |
| 18 | Woodline PartnersWoodline Partners | $10.1M | 1.56% | −27.16% | |
| 19 | Dimensional Fund AdvisorsDimensional | $10.1M | 1.55% | +60.88% | |
| 20 | Goldman Sachs GroupGoldman Sachs | $9.5M | 1.46% | +30.09% | |
| 21 | Jacobs Levy Equity ManagementJacobs Levy Equity | $8.2M | 1.26% | +95.45% | |
| 22 | Acadian Asset ManagementAcadian | $7.8M | 1.20% | −12.81% | |
| 23 | SirenSiren | $7.6M | 1.17% | new | |
| 24 | Qube Research & TechnologiesQube Research & Technologies | $6.3M | 0.97% | +1178.64% | |
| 25 | Renaissance TechnologiesRenaissance Technologies | $5.6M | 0.86% | −4.97% |
135 managers report $649.1M of Design Therapeutics on form 13F for the quarter ended Jun 30 '26. 19 of them hold 80% of it; SR One is largest at 14.55%.
Design Therapeutics, Inc.
10.25
−0.43 · −4.00%
Expected move
Inputs8Q avg ±6.5%·×4.12·rich
straddle ±31.4%
spot 10.68exp Nov 20ATM strike 11ATM straddle 3.95IV 192%
+4.76%
vs ±28.1% implied · ×0.17
shaded = implied · ▲▼ = realized